Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells (original) (raw)
- Brief Communication
- Published: 24 October 2004
Nature Medicine volume 10, pages 1187–1189 (2004)Cite this article
- 1423 Accesses
- 190 Citations
- 6 Altmetric
- Metrics details
Abstract
We studied the effects of Lyn ablation on the survival of drug-resistant chronic myelogenous leukemia (CML) blast crisis cells using siRNA. Lyn siRNA reduced Lyn protein in both normal hematopoietic cells and BCR-ABL1-expressing (BCR-ABL1(+)) blasts by 80–95%. Within 48 h, siRNA-treated BCR-ABL1(+) blasts underwent apoptosis, whereas normal cells remained viable. This increased dependence on Lyn signaling for BCR-ABL1(+) blast survival provides the basis for rational treatment of drug-resistant CML blast crisis, particularly when lymphoid in nature.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Nowell, P.C. & Hungerford, D.A. Science 132, 1497 (1960) (abstract).
Google Scholar - Goldman, J.M. & Melo, J.V. N. Engl. J. Med. 349, 1451–1464 (2003).
Article CAS Google Scholar - Calabretta, B. & Perrotti, D. Blood 103, 4010–4022 (2004).
Article CAS Google Scholar - Amarante-Mendes, G.P. et al. Blood 91, 1700–1705 (1998).
CAS Google Scholar - Druker, B.J. et al. N. Engl. J. Med. 344, 1031–1037 (2001).
Article CAS Google Scholar - Gorre, M.E. et al. Science 293, 876–880 (2001).
Article CAS Google Scholar - Donato, N.J. et al. Blood 101, 690–697 (2003).
Article CAS Google Scholar - Danhauser-Riedl, S. et al. Cancer Res. 56, 3589–3596 (1996).
CAS Google Scholar - Ptasznik, A. et al. J. Exp. Med. 196, 667–678 (2002).
Article CAS Google Scholar - Elbashir, S.M. et al. Nature 411, 494–500 (2001).
Article CAS Google Scholar - Opalinska, J.B. & Gewirtz, A.M. Nat. Rev. Drug Discov. 1, 503–514 (2002).
Article CAS Google Scholar - Hu, Y. et al. Nat. Genet. 36, 453–461 (2004).
Article CAS Google Scholar - Dorsett, Y. et al. Nat. Rev. Drug Discov. 3, 318–329 (2004).
Article CAS Google Scholar - Luger, S. et al. Blood 99, 1150–1158 (2002).
Article CAS Google Scholar - Tatton, L. et al. J. Biol. Chem. 287, 4847–4853 (2003).
Article Google Scholar
Acknowledgements
We thank D. Linnekin for providing us with Lyn cDNA. These studies were supported by grants from the Doris Duke Charitable Foundation (DDCF) to A.M.G., 1R01CA101859-01 (A.M.G.) and RO1CA90833 (S.G.E.) from the US National Institutes of Health, a SCOR grant from the Leukemia and Lymphoma Society (A.M.G. and S.G.E.). A. M. Gewirtz is a Distinguished Clinical Scientist of the DDCF.
Author information
Author notes
- Andrzej Ptasznik, Yuji Nakata and Stephen G Emerson: These authors contributed equally to this work.
Authors and Affiliations
- Division of Hematology/Oncology, Department of Medicine and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, 19104, Pennsylvania, USA
Andrzej Ptasznik, Yuji Nakata, Anna Kalota & Alan M. Gewirtz
Authors
- Andrzej Ptasznik
You can also search for this author inPubMed Google Scholar - Yuji Nakata
You can also search for this author inPubMed Google Scholar - Anna Kalota
You can also search for this author inPubMed Google Scholar - Stephen G Emerson
You can also search for this author inPubMed Google Scholar - Alan M. Gewirtz
You can also search for this author inPubMed Google Scholar
Corresponding authors
Correspondence toAndrzej Ptasznik or Alan M. Gewirtz.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Ptasznik, A., Nakata, Y., Kalota, A. et al. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.Nat Med 10, 1187–1189 (2004). https://doi.org/10.1038/nm1127
- Received: 26 August 2004
- Accepted: 05 October 2004
- Published: 24 October 2004
- Issue Date: 01 November 2004
- DOI: https://doi.org/10.1038/nm1127